During the progression of DN disease, miR-92d-3p interacts with C3 to inhibit the activation of the C3/HMGB1/TGF-β1 pathway and EMT, thereby preventing the progression of DN renal fibrosis. This evidence concerns the gene TGFB1 and liver dysplastic nodule.